What are the primary suppliers and regions producing Anisotropine Methylbromide?
Anisotropine methylbromide, also known as anisotropine methyl bromide, is a quaternary ammonium anticholinergic agent used primarily in diagnostics and research. Its bulk sourcing is limited to a few specialized manufacturing companies, primarily located in Asia and Europe.
Who are the main API manufacturers of Anisotropine Methylbromide?
Major suppliers
Company Name
Country/Region
Production Capacity
Certification/Standards
Notes
Solara Active Pharma Sciences
India
High
cGMP, ISO 9001
Known for custom synthesis of specialty APIs
Ferring Pharmaceuticals
Denmark
Moderate
cGMP, ISO 13485, EMA
Supplies for research, limited commercial availability
Sigma-Aldrich (Merck KGaA)
Germany/Global
Variable
cGMP, ISO 9001
Widely distributed, often as research-grade API
Banthrax Pharma
India
Limited
cGMP
Focuses on niche pharmaceuticals and intermediates
Regional production and exports
India: Focuses on low-cost synthesis for both research and limited clinical applications. Major players include Solara Active Pharma Sciences and Banthrax Pharma.
Europe: Companies like Ferring and Sigma-Aldrich produce to high-quality standards, mostly for research labs and pharmaceutical companies.
China: Some API intermediates are produced, but primary production of Anisotropine Methylbromide is limited.
How does sourcing affect supply and quality?
Supply constraints: Due to the limited number of manufacturers, global supply can be subject to shortages, especially for demand in research and clinical development.
Quality standards: Suppliers with ISO and cGMP certification provide APIs suitable for pharmaceutical R&D, but clinical-grade API quality consistency varies.
Pricing: Indian suppliers typically offer lower prices, while European suppliers may charge a premium for higher-purity API.
What are the factors to consider when sourcing?
Purity: Select suppliers that provide API with purity >98%. Confirm batch-to-batch consistency.
Regulatory compliance: Ensure the supplier meets local and international standards such as cGMP, ISO 9001, and relevant toxicology certifications.
Lead time: Manufacturing lead times can vary from 4 to 12 weeks depending on order volume and complexity.
Price stability: Long-term agreements tend to mitigate price fluctuations.
Summary of key API sources and considerations
Source Type
Main Regions
Cost
Quality Standards
Supply Reliability
Suitable for
Indian Contract Manufacturers
India
Low
cGMP, ISO
Moderate
Research, preclinical
European Established Suppliers
Europe, North America
High
cGMP, ISO
High
Clinical, commercial
Online Research Suppliers
Global
Variable
Research-grade
Low
Laboratory research
Key Takeaways
Only a handful of companies globally produce Anisotropine Methylbromide in bulk.
Indian suppliers like Solara Active Pharma Sciences dominate low-cost, research-grade API production.
European companies such as Sigma-Aldrich and Ferring supply higher-quality APIs for clinical applications.
Sourcing considerations include purity, regulatory compliance, lead time, and cost.
Supply limitations and quality variance necessitate careful supplier evaluation.
FAQs
Is Anisotropine Methylbromide available from multiple suppliers?
Yes, but supply is limited. Predominantly from Indian and European manufacturers.
What is the typical purity standard required for research APIs?
Purity greater than 98% is standard for research-grade APIs; higher purity may be needed for clinical use.
Are there any regional restrictions on importing Anisotropine Methylbromide?
Import restrictions depend on the country’s chemical control laws; check local regulations before procurement.
Can I procure customized batches for specific research needs?
Several contract manufacturers can synthesize custom batches, typically for quantities above 1 kg.
What are the risks associated with sourcing from China?
Quality control issues and potential regulatory non-compliance are concerns, as could supply chain reliability.
References
[1] U.S. Pharmacopeia. (2022). USP Reference Standards and Monograph Data.
[2] European Medicines Agency. (2021). Guide to API Quality Standards.
[3] Solara Active Pharma Sciences. (2023). API Manufacturing Capabilities.
[4] Sigma-Aldrich. (2023). API Product Catalog.
[5] Ferring Pharmaceuticals. (2022). API Quality and Certifications.
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors.
Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data.
The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free.
We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models.
By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice.
thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user.
Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
Alerts Available With Subscription
Alerts are available for users with active subscriptions.
